Advanced Technologies Vastly Improve MRI for Children
National Institute of Biomedical Imaging and BioengineeringNIBIB-supported researchers have significantly reduced the amount of time it takes for a child to undergo an MRI scan at Stanford.
NIBIB-supported researchers have significantly reduced the amount of time it takes for a child to undergo an MRI scan at Stanford.
Four winning teams were announced in the Design by Biomedical Undergraduate Teams (DEBUT) challenge, a biomedical engineering design competition for teams of undergraduate students.
NIBIB-funded researchers have developed an imaging system that rapidly and accurately detects a molecular marker found in brain gliomas. It promises to improve the precision of these difficult surgeries by enabling the complete removal of the tumor, while reducing residual damage to brain tissue and neural function.
Bioengineers have created three-dimensional brain-like tissue that functions like and has structural features similar to tissue in the rat brain and that can be kept alive in the lab for more than two months. The tissue could provide a superior model for studying normal brain function as well as injury and disease, and could assist in the development of new treatments for brain dysfunction.
The National Institute of Biomedical Imaging and Bioengineering will host its second Edward C. Nagy New Investigator Symposium on July 30, 2014 on the NIH campus. There will be ten exciting presentations from recent new investigators covering a wide breadth of NIBIB-funded research.
Researchers have developed a new supercooling technique to increase the amount of time human organs could remain viable outside the body. This study was conducted in rats, and if it succeeds in humans, it would enable a world-wide allocation of donor organs, saving more lives.
Significant funding from NIBIB has enabled researchers to develop a unique technology to help physicians perform ultrasound-guided procedures involving needle placement such as needle biopsies, central line insertion, and local anesthesia.
An international research team has built molecular “clamps” out of DNA that offer a powerful new tool for identifying individuals with an increased risk of cancer.
Four people with paraplegia are able to voluntarily move previously paralyzed muscles as a result of a novel therapy involving electrical stimulation of the spinal cord, according to a study funded in part by the National Institutes of Health and the Christopher & Dana Reeve Foundation.
With the ability to deliver light inside the body in a predictable manner and to host a variety of genetically engineered cells, hydrogels created by NIBIB grantee Andy Yun and colleagues may help address current challenges with applying optogenetic approaches in clinical care.
There are many reasons some people may not get a flu shot, but would they be more likely to do so if there was a simple device that could be mailed directly to them, was easy enough to use by themselves, and provided at least the same level of protection as a traditional flu shot without the pain of a needle jab? A recent NIBIB-funded study suggests the answer is yes.
Skin cancer surgery involves successive removal of tissue, which is processed using a 45 minute procedure to determine if residual cancer remains and is often repeated several times. Now, NIBIB-funded researchers have developed a microscopic technique that identifies residual cancer tissue in 90 seconds, promising to dramatically reduce the length, inefficiency, and cost of this common surgery.
Researchers have developed a tissue scaffold that can deliver gene therapy to wounds over a period of several weeks.
Detecting circulating tumor cells (CTCs) in the blood can play an important role in early diagnosis, characterization of cancer subtypes, treatment monitoring and metastasis. NIBIB-funded researchers have developed a microfluidic system that isolates CTCs more efficiently than current technologies.
An international, multidisciplinary research team has developed an ultrathin membrane that can stick to skin and carry arrays of diagnostic sensors and stimulatory components. The “electronic skin” allows remote patient monitoring and may someday be used to deliver treatments.
NIBIB-funded researchers at Texas A&M are using the unique contraction and expansion properties of shape memory polymer foam to design a much improved treatment for brain aneurysms, which cause severe neurological damage or death for 30,000 Americans each year.
Researchers at NIH have developed two new microscopes, both the first of their kind. The first captures small, fast moving organisms at an unprecedented rate and the second displays large cell samples in three dimensions while decreasing the amount of harmful light exposure to the cells. Both microscopes surpass in clarity any other currently on the market.
As part of the National Robotics Initiative, NIH has awarded funding for three projects to develop the next generation of robots that work cooperatively with people.
NIBIB-funded scientists and engineers are teaming up with neurosurgeons to develop technologies that enable less invasive, image-guided removal of hard-to-reach brain tumors. Their technologies combine novel imaging techniques that allow surgeons to see deep within the brain during surgery with robotic systems that enhance the precision of tissue removal.
Winners announced in the Design by Biomedical Undergraduate Teams (DEBUT) competition for diagnostics, therapeutics, and technologies for underserved populations.
Researchers administered a new method for treating chronic wounds using a novel ultrasound applicator that can be worn like a band-aid. The applicator delivers low-frequency, low-intensity ultrasound directly to wounds, and was found to significantly accelerate healing in five patients with venous ulcers.
A “test run” of radiation therapy in patients with non-Hodgkin lymphoma can show how much radiation is likely to be absorbed by a tumor during actual treatment. This information may help doctors to estimate the dose needed for effective treatment more precisely than currently used measures, such as a person’s height and weight.
A rapid and highly efficient system for transferring large molecules, nanoparticles, and other agents into living cells opens new avenues for disease research and treatment.
Scientists have found a way to sneak nanoparticles carrying tumor-fighting drugs past the immune system.